Butyrophilin protein complex (BTN protein complex (BTN); individual proteins abbreviated as BTN1A1, BTN2A1, BTN3A1, etc.)

The Butyrophilin protein complex encompasses a family of transmembrane glycoproteins structurally related to the B7 family, with key roles in immune modulation, especially the regulation of T cell activation and homeostasis. Core members include BTN1A1, BTN2A1, and BTN3A1, each featuring extracellular immunoglobulin-like domains and, commonly, an intracellular B30.2 domain. BTN3A1 and BTN2A1 function together to sense phosphoantigen metabolites in the cytoplasm, an event critical for the activation of Vγ9Vδ2 γδ T cells—a process relevant in both tumor immunity and infection. These proteins are variably expressed across tissues, notably in the epithelium, immune cells, and lactating mammary gland. Theranostic interest focuses on using monoclonal antibodies and small molecules to modify butyrophilin function for cancer immunotherapy and other immune-mediated pathologies.

Other names

ButyrophilinsBTN familyBTNL proteinsB7-related glycoproteins

Modulation of immune cell activation via phosphoantigen sensing (BTN3A1 B30.2 domain binds intracellular metabolites, triggering γδ T cell activation); Monoclonal antibodies alter BTN3A1 conformation, affecting T cell receptor recognition and signaling; Ligands act as co-stimulatory or co-inhibitory molecules for T cell activity; Inhibition or promotion of cytokine expression and cell cycle entry in T cells